M Noguchi1, N Hiwatashi, Z Liu, T Toyota. 1. Third Department of Internal Medicine, Tohoku University School of Medicine, Sendai, Japan.
Abstract
BACKGROUND: Tumour necrosis factor (TNF) alpha and TNF-beta are soluble ligands binding to TNF receptors with similar activities; soluble TNF receptors neutralise TNF activity by acting as inhibitors. Little is known about the cytokine/soluble receptor role in inflammatory bowel disease (IBD). AIMS: To test the hypothesis that an imbalance in secretion between TNF and TNF inhibitors plays a role in gut inflammation in patients with IBD. METHODS: The secretion of TNF-alpha, TNF-beta, and soluble TNF receptors was compared in the culture supernatants of colonic biopsy specimens and isolated lamina propria mononuclear cells from patients with active colonic IBD. RESULTS: Spontaneous secretion of TNF-alpha in involved IBD mucosa was higher than in normal control and self limited colitis mucosa. Secretion of TNF-beta was higher in patients with Crohn's disease than in those with ulcerative colitis. Soluble TNF receptor in IBD mucosa inhibited TNF activity. Type 2 soluble receptor release from IBD mucosa was increased in active inflammation; release from lamina propria cells was not increased. Mucosal TNF-alpha production correlated with severity of disease. CONCLUSIONS: Results showed enhanced secretion of TNF-alpha but failure to release enhanced amounts of soluble TNF receptor in lamina propria mononuclear cells of patients with IBD. An imbalance in secretion between TNF and TNF inhibitor may be implicated in the pathogenesis of IBD.
BACKGROUND:Tumour necrosis factor (TNF) alpha and TNF-beta are soluble ligands binding to TNF receptors with similar activities; soluble TNF receptors neutralise TNF activity by acting as inhibitors. Little is known about the cytokine/soluble receptor role in inflammatory bowel disease (IBD). AIMS: To test the hypothesis that an imbalance in secretion between TNF and TNF inhibitors plays a role in gut inflammation in patients with IBD. METHODS: The secretion of TNF-alpha, TNF-beta, and soluble TNF receptors was compared in the culture supernatants of colonic biopsy specimens and isolated lamina propria mononuclear cells from patients with active colonic IBD. RESULTS: Spontaneous secretion of TNF-alpha in involved IBD mucosa was higher than in normal control and self limited colitis mucosa. Secretion of TNF-beta was higher in patients with Crohn's disease than in those with ulcerative colitis. Soluble TNF receptor in IBD mucosa inhibited TNF activity. Type 2 soluble receptor release from IBD mucosa was increased in active inflammation; release from lamina propria cells was not increased. Mucosal TNF-alpha production correlated with severity of disease. CONCLUSIONS: Results showed enhanced secretion of TNF-alpha but failure to release enhanced amounts of soluble TNF receptor in lamina propria mononuclear cells of patients with IBD. An imbalance in secretion between TNF and TNF inhibitor may be implicated in the pathogenesis of IBD.
Authors: H Körner; A L Goodsall; F A Lemckert; B J Scallon; J Ghrayeb; A L Ford; J D Sedgwick Journal: Proc Natl Acad Sci U S A Date: 1995-11-21 Impact factor: 11.205
Authors: E J Breese; C A Michie; S W Nicholls; S H Murch; C B Williams; P Domizio; J A Walker-Smith; T T MacDonald Journal: Gastroenterology Date: 1994-06 Impact factor: 22.682
Authors: H M van Dullemen; S J van Deventer; D W Hommes; H A Bijl; J Jansen; G N Tytgat; J Woody Journal: Gastroenterology Date: 1995-07 Impact factor: 22.682
Authors: T A Banks; B T Rouse; M K Kerley; P J Blair; V L Godfrey; N A Kuklin; D M Bouley; J Thomas; S Kanangat; M L Mucenski Journal: J Immunol Date: 1995-08-15 Impact factor: 5.422
Authors: P Anandakumar; S Kamaraj; S Jagan; G Ramakrishnan; S Asokkumar; C Naveenkumar; S Raghunandhakumar; T Devaki Journal: Inflamm Res Date: 2012-06-27 Impact factor: 4.575
Authors: J P Segain; D Raingeard de la Blétière; A Bourreille; V Leray; N Gervois; C Rosales; L Ferrier; C Bonnet; H M Blottière; J P Galmiche Journal: Gut Date: 2000-09 Impact factor: 23.059
Authors: T Gustot; A Lemmers; E Louis; C Nicaise; E Quertinmont; J Belaiche; S Roland; A Van Gossum; J Devière; D Franchimont Journal: Gut Date: 2005-04 Impact factor: 23.059